ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Interventional Pain Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,364Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 15

$837K Total Retail Price of All Prescriptions

Rank: 1 out of 15

916 Patients Receiving at Least One Drug in Part D
33%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

54% of this provider’s 916 patients filled at least one prescription for a schedule two drug, compared to an average of 63%.

Schedule Three
Controlled Substances

54% of this provider’s 916 patients filled at least one prescription for a schedule three drug, compared to an average of 34%.

Risky Drugs to Seniors

5% of this provider’s 3,401 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $83 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
HYDROCODONE-ACETAMINOPHEN 2,788 929 S3 1 1
GABAPENTIN 1,098 290 2 2
OXYCODONE HCL-ACETAMINOPHEN 734 181 S2 3 5
TIZANIDINE HCL 614 152 4 10
ENDOCET 593 194 S2 5 8
MORPHINE SULFATE ER 508 127 S2 6 4
OXYCODONE HCL 392 98 S2 7 3
LYRICA 361 78 8 11
FENTANYL 263 110 S2 9 6
METHOCARBAMOL 247 60 R 10 23
CYCLOBENZAPRINE HCL 245 18 R 11 22
CARISOPRODOL 235 26 R 12 7
TRAMADOL HCL 234 108 13 15
METHADONE HCL 231 58 S2 14 14
OXYCODONE-ACETAMINOPHEN 220 93 S2 15 12
ZOLPIDEM TARTRATE 217 47 16 21
TRAZODONE HCL 212 62 17 26
ROPINIROLE HCL 189 42 18 27
ANASTROZOLE 171 12 19 29
MELOXICAM 166 39 20 17
PROMETHAZINE HCL 165 28 R 21 30
CYMBALTA 157 55 22 16
OXYCONTIN 139 47 S2 23 9
OPANA ER 127 43 S2 24 13
LIDODERM 124 46 25 28
AMITRIPTYLINE HCL 121 33 R 26 24
LIDOCAINE 115 60 27 34
BACLOFEN 96 31 28 20
DICLOFENAC SODIUM 92 0 29 31
POLYETHYLENE GLYCOL 3350 92 40 29 36
IBUPROFEN 78 13 31 37
HYDROMORPHONE HCL 78 23 S2 31 25
AVINZA 73 0 S2 10 33 38
CITALOPRAM HBR 69 15 34 39
MORPHINE SULFATE 68 0 S2 35 18
NAPROXEN 57 0 36 41
VOLTAREN 56 21 37 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 7, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.